Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nephrology].

N Marangon1, C Stoermann-Chopard, P A Triverio

  • 1Service de néphrologie, Départment de médecine générale, Genève.

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small bowel perforation by Anisakis infection due to raw fish consumption: a rare entity to consider.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Score assessment and treatment in patients presenting with low anterior resection syndrome after sphincter-sparing rectal cancer surgery.

International journal of colorectal disease·2025
Same author

Massive Haematochezia due to Splenic Artery Bleeding into the Colon: Unusual Manifestation of Advanced Pancreatic Cancer.

Case reports in surgery·2023
Same author

Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation.

mAbs·2018
Same author

Intra-Abdominal Cooling System Limits Ischemia-Reperfusion Injury During Robot-Assisted Renal Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Access to care in sign language: the French experience.

Public health·2016
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

New dialysis solutions offer a safer alternative for kidney transplant patients, reducing nephrotoxicity and improving biocompatibility. These advancements in immunosuppression and peritoneal dialysis enhance patient outcomes and long-term kidney health.

Area of Science:

  • Nephrology and Transplantation
  • Biomaterials and Regenerative Medicine

Context:

  • Calcineurin inhibitor nephrotoxicity poses a significant challenge in renal transplantation.
  • Alternative immunosuppressive strategies, including sirolimus and enteric-coated mycophenolate sodium, demonstrate reduced nephrotoxicity.
  • Peritoneal dialysis (PD) solutions require evaluation for biocompatibility and long-term effects on mesothelial cells.

Purpose:

  • To explore alternatives to nephrotoxic immunosuppressive regimens in renal transplantation.
  • To assess the biocompatibility of novel peritoneal dialysis solutions using cancer antigen 125 (Ca 125) as a marker.
  • To investigate strategies for mitigating mesothelial cell damage in peritoneal dialysis.

Summary:

  • Sirolimus and enteric-coated mycophenolate sodium offer safer immunosuppression in renal transplantation.

Related Experiment Videos

  • Cancer antigen 125 (Ca 125) in peritoneal effluent indicates mesothelial cell health and dialysis solution biocompatibility.
  • Biocompatible solutions show promise in increasing Ca 125 levels, suggesting improved mesothelial cell viability.

    • Impact:

    • These findings support the clinical feasibility of less nephrotoxic immunosuppressive regimens.
    • Improved peritoneal dialysis solutions may reduce the risk of long-term PD complications like peritoneal sclerosis.
    • Future strategies focusing on reduced glucose exposure and combined osmotic agents could further enhance mesothelial cell protection.